{
  "case_id": "case_0016",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 53.71,
    "sex": "Male",
    "genderIdentity": "Cisgender Female",
    "ancestry": "South Asian"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\n  \nMore precision is possible than: 'bilateral midbrain tegmentum'.  \nNamely: left midbrain.\n  \nRemaining signs are better explained by:\n- right T11 spinal cord, left L5 nerve root, right C6 nerve root and right midbrain lesions\n\nThan the suggested:\n- bilateral length-dependent peripheral polyneuropathy.",
      "structured_data": {
        "gt_lesions_english": [
          "right T11 myelopathy",
          "left L5 radiculopathy",
          "right C6 radiculopathy",
          "left midbrain",
          "right midbrain"
        ],
        "ft_lesions_parsed": [
          {
            "location": "midbrain tegmentum",
            "side": "bilateral",
            "qualifier": null
          },
          {
            "location": "length-dependent peripheral polyneuropathy",
            "side": "bilateral",
            "qualifier": null
          }
        ],
        "exact_matches": [],
        "imprecise_matches": [
          [
            "bilateral midbrain tegmentum",
            "left midbrain"
          ]
        ],
        "missing_lesions_from_ft": [
          "right T11 myelopathy",
          "left L5 radiculopathy",
          "right C6 radiculopathy",
          "right midbrain"
        ],
        "additional_lesions_in_ft": [
          "bilateral length-dependent peripheral polyneuropathy"
        ]
      },
      "scoring": {
        "gt_lesion_count": 5,
        "correctly_identified_count": 0,
        "imprecisely_identified_count": 1,
        "missed_lesion_count": 4,
        "additional_lesion_count": 1,
        "proportion_correct": 0.0,
        "proportion_imprecise": 0.2,
        "proportion_missed": 0.8,
        "proportion_additional": 0.2
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included: Multiple sclerosis\n  \nOther considerations not mentioned:\n\n- Their comorbidity radiculopathy could account for parts of the examination, e.g. with lesions affecting left L5 nerve root and right C6 nerve root.\n  \nThese suggested differentials are reasonable:\n\n- Bickerstaff brainstem encephalitis (anti-GQ1b syndrome); Wernicke encephalopathy; Listeria rhombencephalitis; Midbrain stroke (ischaemic or cavernoma haemorrhage); Brainstem glioma; Chronic progressive external ophthalmoplegia (mitochondrial); Length-dependent axonal polyneuropathy (diabetes or vitamin B12 deficiency)",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Bickerstaff brainstem encephalitis (anti-GQ1b syndrome)",
          "Multiple sclerosis",
          "Wernicke encephalopathy",
          "Listeria rhombencephalitis",
          "Midbrain stroke (ischaemic or cavernoma haemorrhage)",
          "Brainstem glioma",
          "Chronic progressive external ophthalmoplegia (mitochondrial)",
          "Length-dependent axonal polyneuropathy (diabetes or vitamin B12 deficiency)"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation",
          "Radiculopathy": "comorbidity",
          "Sinusitis": "comorbidity",
          "Hypertension": "comorbidity",
          "Non-alcoholic fatty liver disease (NAFLD)": "comorbidity",
          "Obesity": "comorbidity"
        },
        "correctly_mentioned": [
          "Multiple sclerosis"
        ],
        "missing_diagnoses": [
          "Radiculopathy",
          "Sinusitis",
          "Hypertension",
          "Non-alcoholic fatty liver disease (NAFLD)",
          "Obesity"
        ],
        "additional_diagnoses": [
          "Bickerstaff brainstem encephalitis (anti-GQ1b syndrome)",
          "Wernicke encephalopathy",
          "Listeria rhombencephalitis",
          "Midbrain stroke (ischaemic or cavernoma haemorrhage)",
          "Brainstem glioma",
          "Chronic progressive external ophthalmoplegia (mitochondrial)",
          "Length-dependent axonal polyneuropathy (diabetes or vitamin B12 deficiency)"
        ]
      },
      "scoring": {
        "ms_included": 1,
        "incidental_total_count": 0,
        "incidental_missing_count": 0,
        "incidental_missing_proportion": null,
        "comorbidity_total_count": 1,
        "comorbidity_missing_count": 1,
        "comorbidity_missing_proportion": 1.0
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\nAgree with all suggestions.\n\n- MRI including the Brain and Thoracic Spine and CSF test for Oligoclonal Bands would potentially inform a diagnosis of multiple sclerosis.\n\n- MRI including the Cervical Spine and Lumbosacral Spine would potentially inform a diagnosis of radiculopathy.",
      "structured_data": {
        "gt_required_tests": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Thoracic Spine",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Cervical Spine",
            "condition": "Radiculopathy"
          },
          {
            "type": "MRI",
            "region": "Lumbosacral Spine",
            "condition": "Radiculopathy"
          }
        ],
        "ft_proposed_investigations": [
          "MRI of brain and cervical spine with and without gadolinium",
          "MR angiography of head and neck",
          "Lumbar puncture: opening pressure",
          "CSF cell count and differential",
          "CSF protein",
          "CSF glucose (paired serum)",
          "CSF oligoclonal bands and IgG index",
          "CSF bacterial culture and Gram stain",
          "CSF viral PCR panel (HSV, VZV, EBV) and Listeria PCR if available",
          "Anti-ganglioside antibodies including anti-GQ1b IgG",
          "Aquaporin-4 IgG",
          "MOG-IgG",
          "ANA",
          "ENA panel",
          "ACE level",
          "HIV serology",
          "Syphilis serology",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "C-reactive protein",
          "Thyroid-stimulating hormone",
          "Vitamin B12",
          "Methylmalonic acid",
          "Folate",
          "HbA1c",
          "Serum protein electrophoresis with immunofixation",
          "Nerve conduction studies and EMG",
          "Chest CT (if sarcoidosis/malignancy suspected)"
        ],
        "found_tests": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Cervical Spine",
            "condition": "Radiculopathy"
          },
          {
            "type": "MRI",
            "region": "Thoracic Spine",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Lumbosacral Spine",
            "condition": "Radiculopathy"
          }
        ],
        "missing_tests": []
      },
      "scoring": {
        "gt_tests_count": 5,
        "found_tests_count": 5,
        "missing_tests_count": 0,
        "proportion_found": 1.0,
        "proportion_missing": 0.0
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Inappropriate decision to suggest treatment.\n  \nAdditional factors not mentioned:\n\n- Symptoms started more than 14 days\n\nDMTs: Inappropriate omission. The plan failed to consider this possible treatment option.\n  \nAdditional factors not mentioned:\n\n- Need confirmation of MS diagnosis.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "Intravenous thiamine 500 mg TID for 2\u20133 days then taper",
            "timing": "Start Now",
            "reasons": [
              "Ophthalmoplegia and ataxia could represent Wernicke encephalopathy",
              "High benefit and minimal risk",
              "Should precede any glucose administration"
            ]
          },
          {
            "treatment": "Eye protection (lubricating drops/ointment, eyelid taping at night)",
            "timing": "Start Now",
            "reasons": [
              "Severe bilateral ptosis and ophthalmoplegia risk exposure keratopathy"
            ]
          },
          {
            "treatment": "Physiotherapy and gait/balance training; occupational therapy",
            "timing": "Start Now",
            "reasons": [
              "Ataxia and spasticity causing functional impairment",
              "Reduces falls and deconditioning"
            ]
          },
          {
            "treatment": "Low molecular weight heparin for VTE prophylaxis",
            "timing": "Start Now",
            "reasons": [
              "Reduced mobility with bilateral pyramidal signs increases VTE risk"
            ]
          },
          {
            "treatment": "Intravenous immunoglobulin 2 g/kg over 2\u20135 days",
            "timing": "Delay",
            "reasons": [
              "Consider if MRI/CSF/serology support Bickerstaff spectrum or if neurological deficits progress",
              "Balances potential benefit with resource use and adverse effects"
            ]
          },
          {
            "treatment": "Intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Delay",
            "reasons": [
              "Use for inflammatory/demyelinating brainstem disease after infection excluded",
              "Await MRI/CSF to guide therapy"
            ]
          },
          {
            "treatment": "Empiric ampicillin plus gentamicin",
            "timing": "Delay",
            "reasons": [
              "Reserve for clinical or CSF evidence of Listeria rhombencephalitis",
              "Current afebrile, normal inflammatory markers"
            ]
          },
          {
            "treatment": "Baclofen or tizanidine for spasticity",
            "timing": "Delay",
            "reasons": [
              "Introduce after acute diagnostic phase",
              "Titrate to symptom control while monitoring sedation"
            ]
          },
          {
            "treatment": "Treat reversible neuropathy causes (e.g., vitamin B12 replacement, glycaemic optimisation)",
            "timing": "Delay",
            "reasons": [
              "Initiate once laboratory confirmation available",
              "Targets suspected length-dependent neuropathy"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "Intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Delay",
            "reasons": [
              "Use for inflammatory/demyelinating brainstem disease after infection excluded",
              "Await MRI/CSF to guide therapy"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [],
              "contraindications": [
                "Symptoms started more than 14 days"
              ]
            }
          },
          "evaluation_summary": "Inappropriate decision to suggest treatment.\n  \nAdditional factors not mentioned:\n\n- Symptoms started more than 14 days"
        },
        "dmt_evaluation": {
          "ft_plan": null,
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Inappropriate omission. The plan failed to consider this possible treatment option.\n  \nAdditional factors not mentioned:\n\n- Need confirmation of MS diagnosis."
        }
      },
      "scoring": {
        "steroids": {
          "decision_safety": 0,
          "gt_reasons_count": 1,
          "acknowledged_reasons_count": 0,
          "missed_reasons_count": 1,
          "proportion_reasons_acknowledged": 0.0,
          "proportion_reasons_missed": 1.0
        },
        "dmt": {
          "decision_safety": 1,
          "gt_reasons_count": 1,
          "acknowledged_reasons_count": 0,
          "missed_reasons_count": 1,
          "proportion_reasons_acknowledged": 0.0,
          "proportion_reasons_missed": 1.0
        }
      }
    }
  }
}